Home › Funds › Exome Asset Management LLC › VSTM
Exome Asset Management LLC position in VSTM
VERASTEM INC · Health Care
Exome Asset Management LLC reported holding 429,041 shares of VSTM (VERASTEM INC) in its Q2 2026 13F filing — a position valued at US$1.6M, representing 1.01% of its reported portfolio and ranking #38 among its reported holdings. Exome Asset Management LLC has disclosed VSTM holdings in 4 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Exome Asset Management LLC's VSTM position evolved
Exome Asset Management LLC first disclosed a stake in VSTM in Q2 2025 at 599,900 shares (US$2.5M). The position peaked in Q1 2026 at 636,700 shares, worth US$3.4M. Across 4 filings, Exome Asset Management LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 429,041 shares valued at US$1.6M — a reduction of -207,659 shares quarter over quarter.. Notable position changes include a 58% increase in Q1 2026 (shares fell 28% over the following quarter), a 33% trim in Q2 2026 (shares rose 111% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 599.90K | $2.49M | New |
| Q4 2025 | 401.74K | $3.10M | New |
| Q1 2026 | 636.70K | $3.37M | Add |
| Q2 2026 | 429.04K | $1.64M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VSTM and 13F data
VSTM (VERASTEM INC) is a Health Care company. 39 other funds we track also report a position in VSTM — the largest reported positions include ARMISTICE CAPITAL, LLC (US$26.8M), Rosalind Advisors, Inc. (US$15.2M), Nantahala Capital Management, LLC (US$13.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VSTM
- ARMISTICE CAPITAL, LLC 7.02M sh · $26.83M · Q2 2026
- Rosalind Advisors, Inc. 3.99M sh · $15.23M · Q2 2026
- Nantahala Capital Management, LLC 3.58M sh · $13.69M · Q2 2026
- Stonepine Capital Management, LLC 3.35M sh · $12.80M · Q2 2026
- Foresite Capital Management VI LLC 3.15M sh · $12.02M · Q2 2026
- AIGH Capital Management LLC 1.93M sh · $7.36M · Q2 2026
- Opaleye Management Inc. 1.80M sh · $6.88M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.47M sh · $5.61M · Q2 2026
- NEXTBio Capital Management LP 1.31M sh · $4.99M · Q2 2026
More on Exome Asset Management LLC
FAQ
How long has Exome Asset Management LLC held VSTM?
Exome Asset Management LLC has disclosed VSTM holdings in 4 of the last 5 reported quarters, going back to Q2 2025.
What is Exome Asset Management LLC's current position in VSTM?
As of Q2 2026, Exome Asset Management LLC holds 429.04K shares of VSTM (VERASTEM INC), valued at $1.64M, representing 1.01% of its reported portfolio and ranking #38.
Has Exome Asset Management LLC been buying or selling VSTM?
In the latest 13F filing (Q2 2026), Exome Asset Management LLC reduced its position in VSTM. The position peaked in Q1 2026 at 636.70K shares.
Which other funds hold VSTM?
Other major institutional holders of VSTM include ARMISTICE CAPITAL, LLC, Rosalind Advisors, Inc., Nantahala Capital Management, LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.